These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 28766854)

  • 1. Potential misdiagnosis of dysfibrinogenaemia: Data from multicentre studies amongst UK NEQAS and PRO-RBDD project laboratories.
    Jennings I; Kitchen S; Menegatti M; Palla R; Walker I; Peyvandi F; Makris M
    Int J Lab Hematol; 2017 Dec; 39(6):653-662. PubMed ID: 28766854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of Factor XIII deficiency: data from multicentre exercises amongst UK NEQAS and PRO-RBDD project laboratories.
    Jennings I; Kitchen S; Menegatti M; Palla R; Walker I; Makris M; Peyvandi F
    Int J Lab Hematol; 2017 Aug; 39(4):350-358. PubMed ID: 28406553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical phenotype, laboratory features and genotype of 35 patients with heritable dysfibrinogenaemia.
    Shapiro SE; Phillips E; Manning RA; Morse CV; Murden SL; Laffan MA; Mumford AD
    Br J Haematol; 2013 Jan; 160(2):220-7. PubMed ID: 23061815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the fibrinogen Clauss assay and the fibrinogen PT derived method in patients with dysfibrinogenemia.
    Miesbach W; Schenk J; Alesci S; Lindhoff-Last E
    Thromb Res; 2010 Dec; 126(6):e428-33. PubMed ID: 20947138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a novel splicing mutation in the fibrinogen gamma chain gene leading to dysfibrinogenaemia in a Chinese pedigree.
    Huang D; Chen H; Hu X; Wang X; Wang H
    Pathology; 2015 Feb; 47(2):145-50. PubMed ID: 25551304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel fibrinogen variant--Liberec: dysfibrinogenaemia associated with gamma Tyr262Cys substitution.
    Kotlín R; Sobotková A; Suttnar J; Salaj P; Walterová L; Riedel T; Reicheltová Z; Dyr JE
    Eur J Haematol; 2008 Aug; 81(2):123-9. PubMed ID: 18485115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening of dysfibrinogenaemia using the fibrinogen function versus antigen concentration ratio.
    Krammer B; Anders O; Nagel HR; Burstein C; Steiner M
    Thromb Res; 1994 Dec; 76(6):577-9. PubMed ID: 7900105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis, clinical features and molecular assessment of the dysfibrinogenaemias.
    Hill M; Dolan G
    Haemophilia; 2008 Sep; 14(5):889-97. PubMed ID: 18564189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel mutation in exon 2 of FGB caused by c.221G>T
    Shlebak AA; Katsarou AD; Adams G; Fernando F
    J Thromb Thrombolysis; 2017 Feb; 43(2):263-270. PubMed ID: 27812779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congenital dysfibrinogenaemia assessed by whole blood thromboelastography.
    Wei A; Liao L; Xiang L; Yan J; Yang W; Nai G; Luo M; Deng D; Lin F
    Int J Lab Hematol; 2018 Aug; 40(4):459-465. PubMed ID: 29708302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial deletion of the αC-domain in the Fibrinogen Perth variant is associated with thrombosis, increased clot strength and delayed fibrinolysis.
    Westbury SK; Duval C; Philippou H; Brown R; Lee KR; Murden SL; Phillips E; Reilly-Stitt C; Whalley D; Ariëns RA; Mumford AD
    Thromb Haemost; 2013 Dec; 110(6):1135-44. PubMed ID: 24048413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can the phenotype of inherited fibrinogen disorders be predicted?
    Casini A; de Moerloose P
    Haemophilia; 2016 Sep; 22(5):667-75. PubMed ID: 27293018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dysfibrinogenemia leading to resistance to bovine thrombin.
    Depoorter M; Eeckhoudt S
    Acta Clin Belg; 2014 Dec; 69(6):451-3. PubMed ID: 25103594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinogen Nový Jicín and Praha II: cases of hereditary Aalpha 16 Arg-->Cys and Aalpha 16 Arg-->His dysfibrinogenemia.
    Kotlín R; Chytilová M; Suttnar J; Riedel T; Salaj P; Blatný J; Santrůcek J; Klener P; Dyr JE
    Thromb Res; 2007; 121(1):75-84. PubMed ID: 17408725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinogen measurement in cardiac surgery with cardiopulmonary bypass: analysis of repeatability and agreement of Clauss method within and between six different laboratories.
    Solomon C; Baryshnikova E; Tripodi A; Schlimp CJ; Schöchl H; Cadamuro J; Winstedt D; Asmis L; Ranucci M
    Thromb Haemost; 2014 Jul; 112(1):109-17. PubMed ID: 24633448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coexisting congenital dysfibrinogenemia with a novel mutation in fibrinogen γ chain (γ322 Phe→Ile, Fibrinogen Beijing) and haemophilia B in a family.
    Hua B; Li K; Lee A; Poon MC; Zhao Y
    Haemophilia; 2015 Nov; 21(6):846-51. PubMed ID: 25982359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of acquired dysfibrinogenaemia in adult patients with sepsis using fibrinogen function vs. concentration ratios: a cross-sectional study.
    Toenges R; Steiner M; Weber CF; Miesbach W
    Front Med (Lausanne); 2023; 10():1294301. PubMed ID: 38152302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-analytical variables in haemostasis: Findings from the United Kingdom National External Quality Assessment scheme for Blood Coagulation (UK NEQAS BC) haemolysis exercise.
    Brown L; Jennings I; Kitchen S; Kitchen DP; Woods TAL; Walker ID
    Int J Lab Hematol; 2021 Oct; 43(5):1198-1206. PubMed ID: 33605545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of different activators of coagulation by turbidity analysis of hereditary dysfibrinogenemia and controls.
    Marchi R; Neerman-Arbez M; Gay V; Mourey G; Fiore M; Mouton C; Gautier P; De Moerloose P; Casini A
    Blood Coagul Fibrinolysis; 2021 Mar; 32(2):108-114. PubMed ID: 33443927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modified approach to fibrinogen replacement in the setting of dysfibrinogenaemia.
    Chandler JB; Siddon AJ; Bahel P; Torres R; Rinder HM; Tormey CA
    J Clin Pathol; 2019 Feb; 72(2):177-180. PubMed ID: 30463936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.